<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="./datadict_v2.xsl"?><data_table id="pht003007.v1" study_id="phs000547.v1" participant_set="1" date_created="Thu Oct 18 14:39:03 2012"><variable id="phv00174059.v1"><name>garnet_id</name><description>GARNET ID</description><type>integer</type></variable><variable id="phv00174060.v1"><name>randomization1</name><description>First randomization result for intention to treat analysis</description><type>encoded value</type><value code="AA">FEC-DOC/Gem</value><value code="AB">FEC-DOC</value></variable><variable id="phv00174061.v1"><name>ER_status_cumulative</name><description>Overall estrogen receptor status</description><type>encoded value</type><comment>Estrogen receptor status is assessed by local pathologies with immunohistochemistry and is considered positive if more than 9% of tumor cells are positive or immune reactive score (IRS) is over 3</comment><value code="1">Positive</value><value code="2">Negative</value><value code="NA">Not available</value></variable><variable id="phv00174062.v1"><name>HER2_status_cumulative</name><description>HER2/neu status</description><type>encoded value</type><comment>HER2 Status is assessed by local pathologies and is considered to be positive if (DAKO score is 3+) or (DAKO score is 2+ and FISH or CISH or SISH is positive) or (FISH or CISH or SISH is positive)</comment><value code="1">Positive</value><value code="2">Negative</value><value code="3">uncertain (no FISH available)</value><value code="NA">Not available</value></variable><variable id="phv00174063.v1"><name>PR_status_cumulative</name><description>Overall progesterone status</description><type>encoded value</type><comment>Progesterone receptor status is assessed by local pathologies with immunohistochemistry and is considered positive if more than 9% of tumor cells are positive or immune reactive score (IRS) is over 3</comment><value code="1">Positive</value><value code="2">Negative</value><value code="NA">Not available</value></variable><variable id="phv00174064.v1"><name>Age</name><description>Age at randomization</description><type>integer</type><unit>year</unit><logical_min>19</logical_min><logical_max>85</logical_max></variable><variable id="phv00174065.v1"><name>menopause_status</name><description>Menopausal status</description><type>encoded value</type><comment>A patient is considered to be postmenopausal if either laboratory results reveal postmenopausal status or the woman has not menstruated in the past 12 months</comment><value code="1">Premenopausal</value><value code="2">Postmenopausal</value></variable><variable id="phv00174066.v1"><name>height</name><description>Height (to calculate BMI)</description><type>integer</type><unit>cm</unit><logical_min>141</logical_min><logical_max>194</logical_max></variable><variable id="phv00174067.v1"><name>weight</name><description>Weight (to calculate BMI)</description><type>integer</type><unit>kg</unit><logical_min>38</logical_min><logical_max>145</logical_max></variable><variable id="phv00174068.v1"><name>grading</name><description>Grading</description><type>encoded value</type><value code="1">G1 (well differentiated)</value><value code="2">G2 (moderately differentiated)</value><value code="3">G3 (poorly differentiated)</value><value code="NA">Not available</value></variable><variable id="phv00174069.v1"><name>stage_t</name><description>PT according to TNM Classification</description><type>encoded value</type><value code="0">pT0</value><value code="1">pT1</value><value code="2">pT2</value><value code="3">pT3</value><value code="4">pT4</value><value code="NA">Not available</value></variable><variable id="phv00174070.v1"><name>stage_n</name><description>PN according to TNM Classification</description><type>encoded value</type><value code="0">pN0</value><value code="1">pN1</value><value code="2">pN2</value><value code="3">pN3</value><value code="NA">Not available</value></variable><variable id="phv00174071.v1"><name>stage_m</name><description>CM according to TNM Classification</description><type>encoded value</type><value code="0">cM0</value><value code="1">cM1</value><value code="NA">Not available</value></variable><variable id="phv00174072.v1"><name>tumor_type</name><description>Type of histology</description><type>encoded value</type><value code="1">Invasive ductal</value><value code="2">Invasive lobular</value><value code="3">Other invasive epithelial breast cancer</value><value code="NA">Not available</value></variable><variable id="phv00174073.v1"><name>TIME_DEATH</name><description>Observation time for overall survival</description><type>integer</type><unit>day</unit><logical_min>0</logical_min><logical_max>2325</logical_max><comment>Time from date of randomisation until either date of death (from table "study_end") or the maximum of the following dates: randomization, last chemo application (from "chemo"), last zoledronic application (from "zoledron_therapy"), last follow-up (from "follow_up"), last contact (from "study_end")</comment></variable><variable id="phv00174074.v1"><name>STATUS_DEATH</name><description>Overall survival status</description><type>encoded value</type><value code="0">Patient censored</value><value code="1">Event (death) occurred</value></variable><variable id="phv00174075.v1"><name>TIME_PROGRESS</name><description>Observation time for progression-free survival</description><type>integer</type><unit>day</unit><logical_min>0</logical_min><logical_max>2325</logical_max><comment>Time from date of randomisation until either date of first progress (distant metastasis or local recurrence from "chemo_end", "zoledron_end", "follow_up", or death from "study_end") or the maximum of the following dates: randomization, last chemo application (from "chemo"), last zoledronic application (from "zoledron_therapy"), last follow-up from ("follow_up")</comment></variable><variable id="phv00174076.v1"><name>STATUS_PROGRESS</name><description>Progression-free survival status</description><type>encoded value</type><value code="0">Patient censored</value><value code="1">Event (distant metastasis, local recurrence, death) occurred</value></variable><variable id="phv00174077.v1"><name>IS_AE_CYCLE1</name><description>Is there a grade 3 or grade 4 AE (leukopenia, neutropenia or febrile neutropenia) within chemo cycle 1 (yes/no)?</description><type>encoded value</type><value code="-1">Not applicable because chemotherapy was not given</value><value code="0">No</value><value code="1">Yes</value></variable><variable id="phv00174078.v1"><name>IS_AE_CYCLE123</name><description>Is there a grade 3 or grade 4 AE (leukopenia, neutropenia or febrile neutropenia) within chemo cycles 1,2,3 (yes/no)?</description><type>encoded value</type><value code="-1">Not applicable because chemotherapy was not given</value><value code="0">No</value><value code="1">Yes</value></variable><variable id="phv00174079.v1"><name>IS_AE_CYCLE4</name><description>Is there a grade 3 or grade 4 AE (leukopenia, neutropenia or febrile neutropenia) within chemo cycle 4 (yes/no)?</description><type>encoded value</type><value code="-1">Not applicable because patient left study before cycle 4 of chemotherapy</value><value code="0">No</value><value code="1">Yes</value></variable><variable id="phv00174080.v1"><name>IS_AE_CYCLE456</name><description>Is there a grade 3 or grade 4 AE (leukopenia, neutropenia or febrile neutropenia) within chemo cycles 4,5,6 (yes/no)?</description><type>encoded value</type><value code="-1">Not applicable because patient left study before cycle 4 of chemotherapy</value><value code="0">No</value><value code="1">Yes</value></variable></data_table>
